13G Filing: Granite Point Capital and Marinus Pharmaceuticals Inc (MRNS)

Page 11 of 13

Page 11 of 13 – SEC Filing

SIGNATURES

After reasonable
inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in
this statement is true, complete and correct.

DATE: July 18, 2017

GRANITE POINT CAPITAL MASTER FUND, L.P.
By:  Granite Point Capital L.L.C., its general partner
/s/ David Bushley
Name:  David Bushley
Title: Chief Operating Officer
GRANITE POINT CAPITAL PANACEA GLOBAL HEALTHCARE FUND
By:  Granite Point Capital L.L.C., its general partner
/s/ David Bushley
Name:  David Bushley
Title: Chief Operating Officer
GRANITE POINT CAPITAL SCORPION FOCUSED IDEAS FUND
By:  Granite Point Capital L.L.C., its general partner
/s/ David Bushley
Name:  David Bushley
Title: Chief Operating Officer
GRANITE POINT CAPITAL L.L.C.
/s/ David Bushley
Name:  David Bushley
Title: Chief Operating Officer
GRANITE POINT CAPITAL MANAGEMENT, L.P.
By:  GPC 1, LLC, its general partner
/s/ David Bushley
Name:  David Bushley
Title: Chief Operating Officer
WARREN B. LAMMERT, III
/s/ Warren B. Lammert, III
Warren B. Lammert, III, individually

Follow Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)

Page 11 of 13